Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Clesham

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of the Royal Society of Medicine|December 3, 2004
Clinical implications of ST-segment non-resolution after thrombolysis for myocardial infarctionL Bhatia, G J Clesham, D R Turner
International Journal of Cardiology|September 1, 1993
Sarcoid, amyloid and heart failureR D Rakhit, G J Clesham, J G Cleland
Biochemical and Biophysical Research Communications|June 24, 1998
Expression of endoglin mRNA and protein in human vascular smooth muscle cellsP J Adam, G J Clesham, P L Weissberg
International Journal of Clinical Practice|March 7, 1998
Cardiac amyloidosis and the use of diuretic and ACE inhibitor therapy in severe heart failureK L Nash, S O Brij, G J Clesham
Circulation Research|December 1, 1996
Enhancer stimulation unmasks latent gene transfer after adenovirus-mediated gene delivery into human vascular smooth muscle cellsG J Clesham, H Browne, S Efstathiou, et al.
Cytokine|May 11, 2000
Identification and characterisation of transforming growth factor beta-regulated vascular smooth muscle cell genesP J Adam, G J Clesham, P D Flynn, et al.
Gene Therapy|May 14, 1998
High adenoviral loads stimulate NF kappaB-dependent gene expression in human vascular smooth muscle cellsG J Clesham, P J Adam, D Proudfoot, et al.
The American Journal of Cardiology|November 14, 1997
Echocardiographic assessment of cardiac involvement in systemic AL amyloidosis in relation to whole body amyloid load measured by serum amyloid P component (SAP) clearanceG J Clesham, D M Vigushin, P N Hawkins, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of the Royal Society of Medicine|December 3, 2004
Clinical implications of ST-segment non-resolution after thrombolysis for myocardial infarctionL Bhatia, G J Clesham, D R Turner
International Journal of Cardiology|September 1, 1993
Sarcoid, amyloid and heart failureR D Rakhit, G J Clesham, J G Cleland
Biochemical and Biophysical Research Communications|June 24, 1998
Expression of endoglin mRNA and protein in human vascular smooth muscle cellsP J Adam, G J Clesham, P L Weissberg
International Journal of Clinical Practice|March 7, 1998
Cardiac amyloidosis and the use of diuretic and ACE inhibitor therapy in severe heart failureK L Nash, S O Brij, G J Clesham
Circulation Research|December 1, 1996
Enhancer stimulation unmasks latent gene transfer after adenovirus-mediated gene delivery into human vascular smooth muscle cellsG J Clesham, H Browne, S Efstathiou, et al.
Cytokine|May 11, 2000
Identification and characterisation of transforming growth factor beta-regulated vascular smooth muscle cell genesP J Adam, G J Clesham, P D Flynn, et al.
Gene Therapy|May 14, 1998
High adenoviral loads stimulate NF kappaB-dependent gene expression in human vascular smooth muscle cellsG J Clesham, P J Adam, D Proudfoot, et al.
The American Journal of Cardiology|November 14, 1997
Echocardiographic assessment of cardiac involvement in systemic AL amyloidosis in relation to whole body amyloid load measured by serum amyloid P component (SAP) clearanceG J Clesham, D M Vigushin, P N Hawkins, et al.
Pageof 1